Zahra Talebi

7PUBLICATIONS
62CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyIntensive carePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 20, 2025
First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.

A Dimitrios Colevas, Zahra Talebi, Elizabeth Winters

|Jan 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.

Eudocia Q Lee, Brian M Alexander, Carlos G Romo

|Aug 29, 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.

Thomas Drabison, Mike Boeckman, Yan Yang

|Feb 14, 2024
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.

Evanthia T Roussos Torres, Won J Ho, Ludmila Danilova

|Oct 06, 2021
Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia.

Megan E Zavorka Thomas, Jae Yoon Jeon, Zahra Talebi

|Aug 03, 2021
Evaluation of medication reconciliation process in internal medicine wards of an academic medical center by a pharmacist: errors and risk factors.

Shadi Ziaie, Gholamhossein Mehralian, Zahra Talebi

Pageof 2

Frequent Collaborators

2 joint publications

Eric D Eisenmann

2 joint publications

Alex Sparreboom

2 joint publications

Sharyn D Baker

2 joint publications

Josie Silvaroli